1.
Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Global Coronavirus Vaccine Market
4. Executive Summary
5.
Voice of Customer
5.1.
Brand Awareness
5.2.
Vaccine Efficacy
5.3.
Patient Satisfaction Analysis
5.4.
Post-Vaccination Side Effects
6. Global Coronavirus
Vaccine Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value and By
Volume
6.2.
Market Share & Forecast
6.2.1. By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV)
6.2.2. By Vaccine Type (Virus Vaccine, Viral Vector Vaccine,
Nucleic Acid Vaccine, Protein Based Vaccine, Others)
6.2.3. By Product Type (Monovalent Vaccine v/s Multivariant
Vaccine)
6.2.4. By Route of Administration (Intramuscular, Oral,
Intranasal)
6.2.5. By Patient Type (Adult v/s Pediatric)
6.2.6. By End User (Hospitals, Clinics, Research Institutes,
Others)
6.2.7. By Company (2020)
6.2.8. By Region
6.3.
Market Map
7. North America
Coronavirus Vaccine Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Infection Type
7.2.2. By Vaccine Type
7.2.3. By Product Type
7.2.4. By Route of Administration
7.2.5. By Patient Type
7.2.6. By End User
7.2.7. By Country
7.3.
North America: Country Analysis
7.3.1. United States
Coronavirus Vaccine Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Infection Type
7.3.1.2.2.
By Vaccine Type
7.3.1.2.3.
By Product Type
7.3.1.2.4.
By Route of Administration
7.3.1.2.5.
By Patient Type
7.3.1.2.6.
By End User
7.3.2. Mexico Coronavirus
Vaccine Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Infection Type
7.3.2.2.2.
By Vaccine Type
7.3.2.2.3.
By Product Type
7.3.2.2.4.
By Route of Administration
7.3.2.2.5.
By Patient Type
7.3.2.2.6.
By End User
7.3.3. Canada Coronavirus
Vaccine Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Infection Type
7.3.3.2.2.
By Vaccine Type
7.3.3.2.3.
By Product Type
7.3.3.2.4.
By Route of Administration
7.3.3.2.5.
By Patient Type
7.3.3.2.6.
By End User
8. Europe Coronavirus
Vaccine Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Infection Type
8.2.2. By Vaccine Type
8.2.3. By Product Type
8.2.4. By Route of
Administration
8.2.5. By Patient Type
8.2.6. By End User
8.2.7. By Country
8.3.
Europe: Country Analysis
8.3.1. United Kingdom
Coronavirus Vaccine Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Infection Type
8.3.1.2.2.
By Vaccine Type
8.3.1.2.3.
By Product Type
8.3.1.2.4.
By Route of Administration
8.3.1.2.5.
By Patient Type
8.3.1.2.6.
By End User
8.3.2. Germany Coronavirus
Vaccine Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Infection Type
8.3.2.2.2.
By Vaccine Type
8.3.2.2.3.
By Product Type
8.3.2.2.4.
By Route of Administration
8.3.2.2.5.
By Patient Type
8.3.2.2.6.
By End User
8.3.3. France Coronavirus
Vaccine Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Infection Type
8.3.3.2.2.
By Vaccine Type
8.3.3.2.3.
By Product Type
8.3.3.2.4.
By Route of Administration
8.3.3.2.5.
By Patient Type
8.3.3.2.6.
By End User
8.3.4. Italy Coronavirus
Vaccine Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Infection Type
8.3.4.2.2.
By Vaccine Type
8.3.4.2.3.
By Product Type
8.3.4.2.4.
By Route of Administration
8.3.4.2.5.
By Patient Type
8.3.4.2.6.
By End User
8.3.5. Spain Coronavirus
Vaccine Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Infection Type
8.3.5.2.2.
By Vaccine Type
8.3.5.2.3.
By Product Type
8.3.5.2.4.
By Route of Administration
8.3.5.2.5.
By Patient Type
8.3.5.2.6.
By End User
9. Asia-Pacific
Coronavirus Vaccine Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Infection Type
9.2.2. By Vaccine Type
9.2.3. By Product Type
9.2.4. By Route of
Administration
9.2.5. By Patient Type
9.2.6. By End User
9.2.7. By Country
9.3.
Asia-Pacific: Country Analysis
9.3.1. China Coronavirus
Vaccine Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Infection Type
9.3.1.2.2.
By Vaccine Type
9.3.1.2.3.
By Product Type
9.3.1.2.4.
By Route of Administration
9.3.1.2.5.
By Patient Type
9.3.1.2.6.
By End User
9.3.2. India Coronavirus
Vaccine Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Infection Type
9.3.2.2.2.
By Vaccine Type
9.3.2.2.3.
By Product Type
9.3.2.2.4.
By Route of Administration
9.3.2.2.5.
By Patient Type
9.3.2.2.6.
By End User
9.3.3. Singapore
Coronavirus Vaccine Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Infection Type